此页面上的内容需要较新版本的 Adobe Flash Player。

获取 Adobe Flash Player

设为主页 加为收藏
AHA着手制订新版房颤治疗指南
作者:佚名 来源:EGMN   日期:2012-07-05 11:30
本文摘要: “依循指南”(GWTG)是迄今最大规模的以医院为基础的计划,致力于改善心血管疾病患者的治疗质量,涉及卒中、心力衰竭和复苏。美国42%以上的医院参与了这项治疗行动。GWTG计划已在心脏疾病治疗以及卒中治疗中取得了一致改善。GWTG国家指导委员会主席、哈佛大学医学院神经

    美国心脏协会(AHA)正在将房颤(AF)加入其“依循指南”计划。

    “依循指南”(GWTG)是迄今最大规模的以医院为基础的计划,致力于改善心血管疾病患者的治疗质量,涉及卒中、心力衰竭和复苏。美国42%以上的医院参与了这项治疗行动。GWTG计划已在心脏疾病治疗以及卒中治疗中取得了一致改善。GWTG国家指导委员会主席、哈佛大学医学院神经科教授Lee H. Schwamm医生在新闻发布会上说,之前的GWTG中没有涉及AF,而这一领域需要统一的策略。

    “尽管对于AF患者,存在经科学证实的治疗方法,但对于这种常见心律失常疾病的治疗质量仍存在很大差距和分歧。通过在GWTG计划中改善对AF患者的治疗,我们可以挽救患者生命并预防卒中等严重并发症的发生。”
 

 


 
Dr. Lee H. Schwamm
 
 

    AF计划将提供AF治疗策略的“蓝图”。根据声明,尽管这一计划的主要功能是作为一项临床改进指南,但同时也可作为数据收集工具。“(数据收集)为参与的医院提供对其医疗实践和患者预后的反馈,并可用于开发新的AF患者院内治疗循证医学指南。”

    去年,美国心脏协会和美国心脏病学会(ACC)联合对AF治疗建议进行了一次最新证据回顾。协会在其网站上已提供了一些临床和患者数据。

    明年将开始对新的AF模块的入选工作。勃林格殷格翰公司将提供资金,支持美国心脏协会的GWTG–AF计划。

    爱思唯尔  版权所有

    By: MICHELE G. SULLIVAN, Cardiology News Digital Network

    The American Heart Association is adding atrial fibrillation to its "Get With the Guidelines" program.

    Get With the Guidelines has not previously addressed atrial fibrillation. But the current lack of a consistent treatment paradigm suggests the need for a unified strategy, Dr. Lee H. Schwamm said in a press statement.
 
    "While scientifically proven therapies and approaches to treatment exist for patients with atrial fibrillation, wide gaps, variations and disparities remain in the quality of care for people with this common heart rhythm disorder," said Dr. Schwamm, chairman of the Get With the Guidelines National Steering Committee and professor of neurology at Harvard Medical School in Boston. "By improving the care of patients with atrial fibrillation through the GWTG program, we can save lives and prevent serious complications, such as stroke."

    The atrial fibrillation program will provide the "blueprint" for an atrial fibrillation treatment strategy. While its primary function is as a clinical improvement guide, the program will also serve as a data collection tool, according to the statement.

    "[Data collection] gives participating hospitals feedback on their practice and patient outcomes and can be used to develop new evidence-based guidelines for in-hospital care for AF patients."

    GWTG programs have consistently improved care in a number of cardiac disorders, as well as stroke care.

    "Our Get With the Guidelines suite is the ideal home for a nationwide atrial fibrillation quality improvement module, because participation in these programs has proven to make a difference in the quality of care and outcomes for patients with heart disease and stroke," Schwamm said. "In the last decade, numerous scientific studies have shown Get With the Guidelines participating hospitals are more likely to adhere to national guideline-recommended therapies than other U.S. hospitals."

    Last year, the American Heart Association and the American College of Cardiology collaborated on an updated evidence review of atrial fibrillation treatment recommendations.

    The association already offers a number of clinical and patient resources on its website.

    "Get With the Guidelines" is the largest national hospital-based program dedicated to quality of care improvement for patients with cardiovascular disease, including targeted initiatives in stroke, heart failure and resuscitation. More than 42% of U.S. hospitals participate in the quality initiative.

    Enrollment in the new atrial fibrillation module should begin within the next year. Boehringer Ingelheim will provide funding to support the American Heart Association’s GWTG–Atrial Fibrillation program.

(责任编辑:娘娘)
特别声明:本文转载仅仅是出于传播信息的需要,并不意味着代表本网站观点或证实其内容的真实性;如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任;作者如果不希望被转载等事宜,请与我们接洽。  E-mail:editor@media120.com